Skip to main content

Treatment of hemangiomas of infancy

Buy Article:

$51.00 plus tax (Refund Policy)



Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.

Keywords: hemangioma; management; therapy; treatment

Document Type: Research Article


Affiliations: Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI

Publication date: March 1, 2005

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more